Dr. Louise M. Man, MD

Dr. Man practices at Emily Couric Clinical Cancer Center in Charlottesville, Virginia.

Dr. Man's NPI, 1063701852, was assigned on April 1, 2011. Dr. Man graduated from St. George's University School of Medicine in 2011. Dr. Man holds Virginia license 0101262446.

Dr. Man's primary practice is Emily Couric Clinical Cancer Center, at 1240 Lee St,, Charlottesville, VA 22903. The practice phone is (434) 243-4704.

Dr. Man's primary practice is Emily Couric Clinical Cancer Center in Charlottesville, Virginia. Dr. Man is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Man to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Man's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Man practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Man's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Man is board certified in hematology by the American Board of Internal Medicine. Dr. Man is licensed in Virginia.

Dmand AI lists chronic anemia, fluid and electrolyte imbalances and purpura and thrombocytopenia among the conditions Dr. Man treats.

CMS data shows 296 Medicare services from Dr. Man across 8 procedure codes in 2024, for 178 Medicare patients. Medicare paid $26,325 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 178 Medicare patients who saw Dr. Man in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Man's median patient age at 53, with 60% women.

In 2024, Dr. Man wrote 297 Medicare Part D claims for 83 patients. 33% of them were for generic drugs. CMS names the drug for 201 of them, across 4 drugs with 11 or more claims each, at $157,227 in total drug cost. In 2023, CMS named 162 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Man for performance year 2024, reported as part of a group. Dr. Man accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Man as offering telehealth.

Dmand AI links 13 papers to Dr. Man, published from 2013 to 2023. 2022 was the busiest year, with 4. The most frequent topics are Anticoagulants and Tomography, X-Ray Computed. Dr. Man has published most often in Eur J Haematol. Dr. Man's most frequent co-authors are Michael K. Keng, MD, Hillary S. Maitland, MD and Randy Keith Ramcharitar, MD.

CMS Open Payments shows 2 general payments to Dr. Man from 2 drug and device companies in 2018. Consulting fees make up the largest share, 89% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $900.

Dr. Man graduated from St. George's University School of Medicine in 2011.

Dr. Man is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.